Syngene International has announced two key leadership appointments, naming Maninder Kapoor Puri as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO). Both appointments are effective May 1, 2026, and were officially announced on May 4, 2026.
Both leaders will join the company’s Executive Committee, placing them directly at the center of important business and strategic decisions. This includes areas such as growth planning, operations, and global expansion, making these appointments significant at the leadership level.
Top-Level Changes
This announcement comes alongside a broader change in the company’s senior leadership. On April 30, 2026, multiple executives stepped down from key roles, including positions in commercial leadership, human resources, and strategic collaborations.
The fact that new leaders have taken charge immediately after these exits shows that the transition was planned in advance. Instead of isolated hiring, this reflects a structured shift where critical leadership roles are being replaced together.
Such coordinated changes at the senior level usually indicate that a company is reorganizing how it operates, especially in areas that directly impact both business performance and internal management.
Key Appointments
Maninder Kapoor Puri brings close to 30 years of experience in human resources. Her career spans industries such as biopharmaceuticals, IT services, and consulting, with experience working across regions including North America, Europe, and Asia Pacific.
She previously served as CHRO at Biocon, where she was involved in driving changes in organizational culture and leadership development. She also held the position of Global CHRO at Mastek, managing HR operations across more than 40 countries.
At Syngene, she will be responsible for shaping the company’s people strategy. This includes building leadership capability, managing talent, and ensuring that the organization is aligned with its business priorities.
Abhijit Zutshi has around 27 years of experience in the pharmaceutical industry. He spent 25 years at Biocon, where he worked across commercial roles and played a role in expanding the company’s business in global markets.
His experience covers sales, marketing, and client management, along with building and leading commercial teams. At Syngene, he will oversee global commercial operations, including client partnerships, revenue growth, and expansion into new markets.
Role Significance
The CHRO and CCO roles play a key part in how the company operates and grows, as they cover both the internal and external sides of the business.
- CHRO: Focuses on managing the workforce, including hiring, leadership development, and building a strong organizational structure
- CCO: Focuses on business growth, including revenue, client relationships, and expansion into global markets
By appointing both roles at the same time and including them in the Executive Committee, Syngene International is strengthening both its internal leadership structure and its outward business operations together, ensuring that both areas are aligned at the top level.
Company and Operations Overview
Syngene International operates as a global contract research, development, and manufacturing organization that supports pharmaceutical and biotechnology companies across different stages of product development. Its work covers everything from early research and testing to large scale manufacturing.
The company has more than 8,300 employees, including over 5,700 scientists, which reflects the scale of its scientific and research capabilities. It also operates large research and manufacturing facilities across India and the United States, allowing it to serve both domestic and international markets.
Syngene works with around 400 global clients, including major pharmaceutical and biotechnology companies. Its services are used across the full lifecycle of drug development, starting from early stage discovery and moving through development and commercial production.
Conclusion
The appointment of a new CHRO and CCO, along with the exit of multiple senior executives, points to a coordinated leadership transition within Syngene International rather than a routine update. The close timing of these changes shows that key leadership roles have been realigned together, especially in areas that directly impact both workforce management and commercial operations.
With both positions now part of the Executive Committee, the company has strengthened leadership in two critical areas, people strategy and business growth. These roles play a direct role in how the company manages talent, builds leadership pipelines, and expands its client base across global markets.
Taken together, these changes highlight a clear shift in the company’s leadership structure, where both internal operations and external business functions are being reinforced at the same time.
